| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/07/2001 | CN1286255A Pyridine compounds, their preparation method and pharmaceutical compositions contg them |
| 03/07/2001 | CA2317324A1 Oxidation process for preparing quinacridone pigments |
| 03/06/2001 | US6197975 7-azabicyclo(2.2.1)heptane-7-carbonyl-substituted 2-phenylindole derivatives; sexual disorders; anticarcinogenic agents |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197783 Therapy for gastrointestinal disorders |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197772 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives |
| 03/06/2001 | US6197771 Nervous system disorders; antiischemic agents; alzheimer'sdisease; parkinson's disease; huntington's disease |
| 03/06/2001 | US6197768 Therapy, prevention ischemic heart disease |
| 03/06/2001 | US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
| 03/06/2001 | US6197339 Dihydro-5-methylamino-4h-imidazo(4,5-ij)quinoline-2(1h)one butenedioate with starches and hydroxypropyl cellulose |
| 03/06/2001 | CA2223081C Heterocyclic ring-fused pyrimidine derivatives |
| 03/01/2001 | WO2001014381A1 Ether derivatives of pyrrolo[1,2-a]quinoxalines, method for producing them and their use in therapy |
| 03/01/2001 | WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/01/2001 | WO2001014376A1 Novel spiro compounds |
| 03/01/2001 | WO2001014375A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 03/01/2001 | WO2001014348A1 Formation of heterocycles |
| 03/01/2001 | WO2001014328A2 Substituted ureas as cell adhesion inhibitors |
| 03/01/2001 | WO2001014288A1 Optically active isocyanurate and optical resolver comprising derivative of the same |
| 03/01/2001 | WO2001013917A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | WO2000009505A9 Naphthyridine derivatives |
| 03/01/2001 | CA2381111A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 02/28/2001 | EP1078928A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077979A1 Method for producing (s,s)-benzyl-2,8-diazabicyclo 4.3.0]nonane |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077701A1 Anti-viral compounds |
| 02/28/2001 | CN1285834A Fused pyrazine compound |
| 02/28/2001 | CN1285832A Synthesis of long-wavelength absorbing photosensitizers |
| 02/28/2001 | CN1285821A Aryl Fused azapolycyclic compounds |
| 02/27/2001 | US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety |
| 02/27/2001 | US6194430 Viral treatment |
| 02/27/2001 | US6194428 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system |
| 02/27/2001 | US6194426 5,6,7,8 tetrahydroindolizines derivatives |
| 02/27/2001 | US6194425 Viricides, antitumor agents |
| 02/27/2001 | US6194424 Arylacetamides and their use as medicaments |
| 02/27/2001 | US6194422 Antibiotic; amyloidoses therapy |
| 02/27/2001 | US6194416 Central nervous system disorders; alzheimer's disease |
| 02/27/2001 | US6194407 Incontinence |
| 02/27/2001 | US6194132 Photographic element, compound, and process |
| 02/27/2001 | CA2317053A1 New pyridine derivatives, the process for preparing them and the pharmaceutical compositions that contain them |
| 02/27/2001 | CA2212784C Piperidinylamino tricyclic compounds as substance p antagonists |
| 02/27/2001 | CA2111204C Piperidine derivatives having anxiolytic effect |
| 02/27/2001 | CA2107485C Ellipticin derivatives, their preparation process and pharmaceutical compositions containing them |
| 02/22/2001 | WO2001012632A2 Phenanthroline-7-one derivatives and their therapeutic uses |
| 02/22/2001 | WO2001012631A2 Ascididemin derivatives and their therapeutic applications |
| 02/22/2001 | WO2001012630A1 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 02/22/2001 | WO2001012629A1 Azaindoles having serotonin receptor affinity |
| 02/22/2001 | WO2001012612A1 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 02/22/2001 | WO2001012602A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 02/22/2001 | WO2001012600A1 INHIBITORS OF FACTOR Xa |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2001012180A2 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune responce |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | CA2698353A1 Pharmaceutical compounds |
| 02/22/2001 | CA2393965A1 Ascididemin derivatives and their therapeutic applications |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/22/2001 | CA2381352A1 Phenanthroline-7-one derivatives and their therapeutic uses |
| 02/22/2001 | CA2381090A1 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 02/22/2001 | CA2377637A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 02/21/2001 | EP1076656A2 N-heteroaryl-substituted pyridine derivatives and their use as herbicides |
| 02/21/2001 | EP1076655A1 N-pyridonyl herbicides |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284956A Novel bispidine antiarrhythmic compounds |
| 02/21/2001 | CN1284955A 整联蛋白受体拮抗剂 Integrin receptor antagonists |
| 02/21/2001 | CN1284952A Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284874A 5-HT1F agonists |
| 02/21/2001 | CN1284866A Oral pharmaceutical extended release dosage form |
| 02/20/2001 | US6191161 Prolylendopeptidase inhibitors |
| 02/20/2001 | US6191160 Spiro-indolines as Y5 receptor antagonists |
| 02/20/2001 | US6191141 Psychological disorders; nervous systen disorders |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/20/2001 | US6191070 Pyrimidinone derivatives and herbicides containing them |
| 02/20/2001 | CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/15/2001 | WO2001010867A1 Vitronectin receptor antagonists useful for the treatment of strokes |
| 02/15/2001 | WO2001010862A2 Substituted heterocyclybenzofuranes |
| 02/15/2001 | WO2001010861A2 Substituted heterocyclyl-2h-chromenes |
| 02/15/2001 | WO2001010860A2 Quinazolinone and azaquinazolinone derivatives |
| 02/15/2001 | WO2001010847A2 Novel integrin receptor antagonists |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | WO2001010465A1 Moxifloxacin formulation containing common salt |
| 02/15/2001 | WO2001010380A2 Benzanilides as potassium channel openers |
| 02/15/2001 | DE19937772A1 Substituierte Heterocyclyl-2GH-chromene Substituted heterocyclyl 2GH-chromene |
| 02/15/2001 | DE19937500A1 Substituierte Heterocyclylbenzofurane Substituted Heterocyclylbenzofurane |
| 02/15/2001 | DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin |
| 02/15/2001 | CA2381500A1 Substituted heterocyclyl-2h-chromenes |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2379977A1 Novel integrin receptor antagonists |